ANGO ANGIODYNAMICS INC

Nasdaq angiodynamics.com


$ 11.52 $ -0.18 (-1.54 %)    

Friday, 17-Oct-2025 15:59:56 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 11.54
$ 11.68
$ 11.30 x 5
$ 12.38 x 276
$ 11.42 - $ 11.84
$ 6.29 - $ 13.50
430,153
na
475.45M
$ 0.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-02-2025 08-31-2025 10-Q
2 07-18-2025 05-31-2025 10-K
3 04-02-2025 02-28-2025 10-Q
4 01-08-2025 11-30-2024 10-Q
5 10-03-2024 08-31-2024 10-Q
6 07-25-2024 05-31-2024 10-K
7 04-09-2024 02-29-2024 10-Q
8 01-08-2024 11-30-2023 10-Q
9 10-05-2023 08-31-2023 10-Q
10 08-03-2023 05-31-2023 10-K
11 03-31-2023 02-28-2023 10-Q
12 01-06-2023 11-30-2022 10-Q
13 10-11-2022 08-31-2022 10-Q
14 07-22-2022 05-31-2022 10-K
15 04-07-2022 02-28-2022 10-Q
16 01-07-2022 11-30-2021 10-Q
17 09-30-2021 08-31-2021 10-Q
18 07-27-2021 05-31-2021 10-K
19 03-31-2021 02-28-2021 10-Q
20 01-08-2021 11-30-2020 10-Q
21 10-07-2020 08-31-2020 10-Q
22 08-10-2020 05-31-2020 10-K
23 04-08-2020 02-29-2020 10-Q
24 01-08-2020 11-30-2019 10-Q
25 10-04-2019 08-31-2019 10-Q
26 07-25-2019 05-31-2019 10-K
27 04-02-2019 02-28-2019 10-Q
28 01-07-2019 11-30-2018 10-Q
29 10-01-2018 08-31-2018 10-Q
30 07-23-2018 05-31-2018 10-K
31 04-05-2018 02-28-2018 10-Q
32 01-05-2018 11-30-2017 10-Q
33 09-29-2017 08-31-2017 10-Q
34 08-04-2017 05-31-2017 10-K
35 04-03-2017 02-28-2017 10-Q
36 01-06-2017 11-30-2016 10-Q
37 10-05-2016 08-31-2016 10-Q
38 08-01-2016 05-31-2016 10-K
39 04-11-2016 02-29-2016 10-Q
40 01-08-2016 11-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 angiodynamics-eyes-growth-despite-tariffs

AngioDynamics (ANGO) exceeds expectations, raises guidance for fiscal 2026 with positive cash flow expected.

 canaccord-genuity-maintains-buy-on-angiodynamics-raises-price-target-to-18

Canaccord Genuity analyst William Plovanic maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from...

 crude-oil-down-2-aspire-biopharma-shares-spike-higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow trade...

 whats-fueling-the-momentum-in-angiodynamics-stock

Shares of AngioDynamics, Inc. (NASDAQ: ANGO) are up Thursday after the biotechnology company raised guidance for four key finan...

 angiodynamics-raises-fy2026-adj-eps-guidance-from-035-025-to-033-023-vs-031-est-raises-fy2026-sales-guidance-from-305000m-310000m-to-308000m-313000m-vs-307200m-est

AngioDynamics (NASDAQ:ANGO) raises FY2026 Adj EPS guidance from $(0.35)-$(0.25) to $(0.33)-$(0.23) vs $(0.31) analyst estimate....

 angiodynamics-q1-adj-eps-010-beats-012-estimate-sales-75711m-beat-72725m-estimate

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12)...

 stock-market-today-dow-futures-slip-sp-500-rises-amid-mixed-tradeberkshire-occidental-fermi-in-focus

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices w...

 sp-500-closes-at-record-high-investor-sentiment-improves-fear--greed-index-remains-in-neutral-zone

CNN Business Fear & Greed Index at 52.3, remaining in Neutral zone. Stocks close higher despite economic headwinds, with re...

 angiodynamics-globant-and-3-stocks-to-watch-heading-into-thursday

US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics.

 angiodynamics-enrolls-first-patient-in-randomized-study-of-ambition-below-the-knee

Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee BlockagesAngioDynamics, Inc. (NASD...

 angiodynamics-publishes-preserve-study-of-nanoknife-system-for-prostate-tissue-ablation-in-european-urology

Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy...

 lake-street-initiates-coverage-on-angiodynamics-with-buy-rating-announces-price-target-of-24

Lake Street analyst Frank Takkinen initiates coverage on AngioDynamics (NASDAQ:ANGO) with a Buy rating and announces Price T...

 hc-wainwright--co-reiterates-buy-on-angiodynamics-maintains-16-price-target

HC Wainwright & Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:ANGO) with a Buy and maintains $16 price target.

 canaccord-genuity-maintains-buy-on-angiodynamics-raises-price-target-to-17

Canaccord Genuity analyst William Plovanic maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION